Cheapest P/E in Healthcare
The lowest price-to-earnings companies in the Healthcare sector.
As of Oct 26, 2026
| # | Company | Industry | Price | Mkt Cap | P/E | P/B | ROE | Net Margin | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RIGL | Biotechnology | $48.13 | $899.06M | 2.45 | 2.11 | 86.3% | 124.7% | 64.1% | — |
| 2 | GMAB | Biotechnology | $43.79 | $2.81B | 2.92 | 0.48 | 16.5% | 25.9% | 19.2% | — |
| 3 | NVAX | Biotechnology | $9.70 | $1.60B | 3.63 | — | — | 39.2% | 64.7% | — |
| 4 | FMS | Medical - Care Facilities | $22.68 | $6.33B | 5.09 | 0.59 | 11.5% | 23.6% | 5.9% | 3.53% |
| 5 | ZVRA | Biotechnology | $9.81 | $582.55M | 7.00 | 2.68 | 38.2% | 78.2% | 350.9% | — |
| 6 | BCRX | Biotechnology | $7.65 | $1.95B | 7.41 | — | — | 30.2% | 94.1% | — |
| 7 | AUPH | Pharmaceutical Preparations | $16.86 | $2.24B | 7.81 | 3.65 | 46.7% | 101.5% | 20.4% | — |
| 8 | TBPH | Biotechnology | $17.03 | $884.18M | 8.35 | 3.05 | 36.6% | 98.5% | 66.9% | — |
| 9 | ACAD | Biotechnology | $19.73 | $3.40B | 8.69 | 2.60 | 29.9% | 36.5% | 11.9% | — |
| 10 | THC | Medical - Care Facilities | $268.45 | $21.62B | 9.13 | 4.64 | 50.8% | 11.1% | 3.1% | — |
| 11 | INMD | Medical - Devices | $13.97 | $885.12M | 9.43 | 1.30 | 13.7% | 25.3% | -6.2% | — |
| 12 | AMPH | Drug Manufacturers - Specialty & Generic | $25.14 | $1.07B | 10.90 | 1.39 | 12.8% | 13.6% | -1.7% | — |
| 13 | MDXG | Biotechnology | $3.91 | $569.92M | 11.73 | 2.64 | 22.5% | 11.6% | 20.0% | — |
| 14 | PBH | Medical - Pharmaceuticals | $47.80 | $2.26B | 11.90 | 1.18 | 9.9% | 17.5% | -4.3% | — |
| 15 | AVAH | Medical - Care Facilities | $13.38 | $2.92B | 12.97 | 10.16 | 78.3% | 9.2% | 20.2% | — |
| 16 | BIO-B | Medical - Devices | $364.15 | $10.08B | 13.26 | 1.40 | 10.6% | 29.4% | 0.7% | — |
| 17 | BHC | Pharmaceutical Preparations | $6.44 | $2.41B | 15.34 | — | — | 1.5% | 6.7% | 19.88% |
| 18 | RDY | Drug Manufacturers - Specialty & Generic | $13.21 | $11.03B | 16.63 | 2.82 | 17.0% | 17.4% | 13.8% | — |
| 19 | ELV | Medical - Healthcare Plans | $439.95 | $95.05B | 16.79 | 2.13 | 12.7% | 2.8% | 12.5% | 1.35% |
| 20 | REGN | Pharmaceutical Preparations | $805.02 | $76.00B | 16.87 | 2.40 | 14.2% | 31.4% | 1.0% | — |
| 21 | RICHT.BD | Drug Manufacturers - Specialty & Generic | $13,170.00 | $2.73T | 17.54 | 2.60 | 14.8% | 19.4% | 27.3% | — |
| 22 | BMY | Drug Manufacturers - General | $61.48 | $125.59B | 17.80 | 5.63 | 31.6% | 14.6% | -0.2% | 4.05% |
| 23 | CPRX | Biotechnology | $31.49 | $3.85B | 17.98 | 3.81 | 21.2% | 36.4% | 19.8% | — |
| 24 | PBYI | Biotechnology | $11.02 | $568.85M | 18.28 | 4.11 | 22.5% | 13.6% | -0.9% | — |
| 25 | UTHR | Biotechnology | $587.50 | $25.20B | 18.88 | 3.94 | 20.9% | 41.9% | 10.6% | — |
Dated archive
Permanent snapshots of this list, frozen each day.
- 2026-10-26 25 stocks
- 2026-10-24 25 stocks
- 2026-10-22 25 stocks
- 2026-10-20 25 stocks
- 2026-10-18 25 stocks
- 2026-10-16 25 stocks
- 2026-10-14 25 stocks
- 2026-10-12 25 stocks
- 2026-10-10 25 stocks
- 2026-10-08 25 stocks
- 2026-10-06 25 stocks
- 2026-10-04 25 stocks
- 2026-10-02 25 stocks
- 2026-09-30 25 stocks
- 2026-09-28 25 stocks
- 2026-09-25 25 stocks
- 2026-09-23 25 stocks
- 2026-09-21 25 stocks
- 2026-09-19 25 stocks
- 2026-09-17 25 stocks
- 2026-09-15 25 stocks
- 2026-09-13 25 stocks
- 2026-09-11 25 stocks
- 2026-09-09 25 stocks
- 2026-09-07 25 stocks
- 2026-09-05 25 stocks
- 2026-09-03 25 stocks
- 2026-09-01 25 stocks
- 2026-08-30 25 stocks
- 2026-08-28 25 stocks
- 2026-08-26 25 stocks
- 2026-08-24 25 stocks
- 2026-08-22 25 stocks
- 2026-08-20 25 stocks
- 2026-08-18 25 stocks
- 2026-08-16 25 stocks
- 2026-08-14 25 stocks
- 2026-08-12 25 stocks
- 2026-08-10 25 stocks
- 2026-08-08 25 stocks
- 2026-08-06 25 stocks
- 2026-08-04 25 stocks
- 2026-08-02 25 stocks
- 2026-07-31 25 stocks
- 2026-07-29 25 stocks
- 2026-07-27 25 stocks
- 2026-07-25 25 stocks
- 2026-07-23 25 stocks
- 2026-07-21 25 stocks
- 2026-07-19 25 stocks
- 2026-07-17 25 stocks
- 2026-07-15 25 stocks